参考文献/References:
[1] Elkind MSV,Luna JM,Moon YP,et al.Infectious burden and carotid plaque thickness:the northern Manhattan study[J].Journal of Vascular Surgery,2010,52(3):797-798.
[2] Mayr M,Kiechl S,Willeit J,et al.Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis[J].Circulation,2000,102(8):833-839.
[3] Markus HS,Mendall MA.Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma[J].J Neurol Neurosurg Psychiatry,1998,64(1):104-107.
[4] Nazligul Y,Aslan M,Horoz M,et al.The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected[J].Clin Biochem,2011,44(8/9):647-649.
[5] Vijayvergiya R,Vadivelu R.Role of helicobacter pylori infection in pathogenesis of atherosclerosis[J].World J Cardiol,2015,7(3):134-143.
[6] Umeda M,Kobayashi H,Takeuchi Y,et al.High prevalence of Helicobacter pylori detected by PCR in the oral cavities of periodontitis patients[J].J Periodontol,2003,74(1):129-134.
[7] Vafaeimanesh J,Hejazi SF,Damanpak V,et al.Association of helicobacter pylori infection with coronary artery disease: is helicobacter pylori a risk factor?[J].ScientificWorldJournal,2014(2):516354.
[8] Izadi M,Fazel M,Shanibandi SH,et al.Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease[J].Cardiovascular Pathology,2012,21(4):307-311.
[9] Rafiean-Kopaei M,Baradaran A,Maghsoudi AR,et al.Helicobacter pylori infection and serum homocysteine in hemodialysis patient[J].Life science journal,2012,9(4):3696-3702.
[10] Tousoulis D, Davies GJ,Asimakopoulos G,et al.Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries(syndrome X)[J].Clin Cardiol,2001,24(4):301-304.
[11] Fabricant CG,Fabricant J,Minick CR,et al.Herpesvirus-induced atherosclerosis in chickens[J].Fed Proc,1983,42(8):2476-2479.
[12] Fallah S,Moradi N,Reza F,et al.Helicobacter pylori Infection is a Significant Factor Risk for Hyperhomocysteinemia in the Patients with Coronary Artery Disease[J].Brazilian Archives of Biology and Technology,2016,59:e16150509.
[13] Chen BF,Xu X,Deng Y,et al.Relationship between Helicobacter pylori infection and serum interleukin-18 in patients with carotid atherosclerosis[J].Helicobacter,2013,18(2):124-128.
[14] Xu Y,Wang Q,Liu Y,et al.Association between Helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia[J].J Neurol Sci,2016,362:73-77.
[15] Matusiak A,Chaubiński M,Broncel M,et al.Putative Consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation[J].Arch Med Sci,2016,12(1):45-54.
[16] Kleinbongard P,Schultz R,Heusch G.TNF-alpha in ath-erosclerosis,myocardial ischemia/reperfusion,remodel-ling and heart failure[J].Heart Fail Rev,2011,16(1):49-69.
[17] Baars T,Konorza T,Kahlert P,et al.Coronary aspirate TNF-alpha reflects saphenous vein bypass graft rest-enosis risk in diabetic patients[J].Cardiovasc Diabetol,2013,12(1):12.
[18] Gajewski A, Mnich E, Szymański K, et al. Helicobacter pyloriantigens, acetylsalicylic acid, LDL and 7-ketocholesterol-their potential role in destabilizing the gastric epithelial cell barrier. An in vitro model of bato Ⅲ cells[J].Acta Biochemica Polonica,2015,63(1):145.
[19] Oshima T,Ozono R,Yano Y,et al.Association of helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects[J].J Am Coll Cardiol,2005,45(8):1219-1222.
[20] Blum A,Tamir S,Mualem K,et al.Endothelial dysfunction is reversible in Helicobacter pylori-positive subjects[J].Am J Med,2011,124(12):1171-1174.
[21] Matsuura E,Kobayashi K,Matsunami Y,et al.Autoimmunity, infectious immunity, and atherosclerosis[J].J Clin Immunol,2009,29(6):714-721.
[22] Davington J,Granz P.Role of endothelial dysfunction in atherosclerosis[J].Circulation,2004,109(Suppl.1):1127-1132.
[23] Sheikine Y, Hansson GK. Chemokines and atherosclerosis[J].Ann Med, 2004, 36(2):98-118.
[24] Hirsch AT,Folsom AR.The continuum risk: Vascular pathophysiology, function and structure [J]. Circulation, 2004, 110(18):2774-2777.
[25] Hassan M,Ansari K,Omrani MD,et al.Effect of helicobacter pylori infection on the lipid,lipoproteins,apolipoprotein-A1,lipoprotein(a)and Apolipoprotein-B in patients with gastritis[J].African journal of microbiology research,2010,4(2):84-87.
[26] Akbas HS,Basyigit S,Suleymanlar I,et al.The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects[J].Lipids Health Dis,2010,9(1):92.
[27] Niemelä S,Karttunen T,Korhonen T,et al.Could helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?[J].Heart,1996,75(6):573-575.
[28] Pieniazek P,Karczewska E,Duda A,et al.Association of helicobacter pylori infection with coronary heart disease[J].J Physiol Pharmacol,1999,50(5):743-751.
[29] Fagoonee S,De Angelis C,Elia C,et al.Potential Link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis?[J].Minerva Med,2010,101(2):121-125.
[30] Elizalde JI,Gómez J,Panés J,et al.Platelet activation In mice and human Helicobacter pylori infection[J].J Clin Invest,1997,100(5):996-1005.
[31] Byrne MF,Murphy JF,Corcoran PA,et al.Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells[J].Scand J Gastroenterol,2003,38(10):1023-1030.
[32] Nazligul Y,Aslan M,Horoz M,et al.The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected[J].Clin Biochem,2011,44(8/9):647-649.